000 01623 a2200457 4500
005 20250515180037.0
264 0 _c20100128
008 201001s 0 0 eng d
022 _a1466-609X
024 7 _a10.1186/cc7949
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Li-Fu
245 0 0 _aUnfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.
_h[electronic resource]
260 _bCritical care (London, England)
_c2009
300 _aR108 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aBase Sequence
650 0 4 _aBody Water
650 0 4 _aDNA Primers
650 0 4 _aEnoxaparin
_xpharmacology
650 0 4 _aHeparin
_xpharmacology
650 0 4 _aImmunohistochemistry
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPlasminogen Activator Inhibitor 1
_xgenetics
650 0 4 _aProspective Studies
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aRespiration, Artificial
_xadverse effects
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aVentilator-Induced Lung Injury
_xmetabolism
700 1 _aHuang, Chung-Chi
700 1 _aLin, Horng-Chyuan
700 1 _aTsai, Ying-Huang
700 1 _aQuinn, Deborah A
700 1 _aLiao, Shuen-Kuei
773 0 _tCritical care (London, England)
_gvol. 13
_gno. 4
_gp. R108
856 4 0 _uhttps://doi.org/10.1186/cc7949
_zAvailable from publisher's website
999 _c18996413
_d18996413